Centiva Capital’s Envoy Medical COCH Stock Holding History

Centiva Capital’s Portfolio COCH Stock Details COCH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-170,633	Closed	-$1.72M	–	1568
2022 Q4	$1.72M	Hold	170,633	–	–	0.05%	401
2022 Q3	$1.68M	Hold	170,633	–	–	0.03%	413
2022 Q2	$1.67M	Buy	170,633 +10,375	+6%	+$102K	0.04%	409
2022 Q1	$1.57M	Hold	160,258	–	–	0.03%	520
2021 Q4	$1.56M	Buy	160,258 +60,258	+60%	+$588K	0.03%	435
2021 Q3	$970K	Hold	100,000	–	–	0.06%	348
2021 Q2	$970K	Buy	+100,000	New	+$972K	0.02%	583

Other funds holding COCH

AMC

Atlas Merchant Capital New York $789K AUM 60.67% 1-Year Est. Return

SIM

Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

FTCM

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

KPF

K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Centiva Capital's COCH Position: Q1 2023 in Review

Centiva Capital sold out of Envoy Medical (COCH) in Q1 2023, closing a stake of 170,633 shares — an estimated $1.72M sold.

Centiva Capital first reported a position in COCH in Q2 2021 and held it in 7 quarters. The position peaked at $1.72M in Q4 2022. 24 funds tracked by Wall St. Rank hold COCH as of Q1 2023.

Centiva Capital reported no remaining Envoy Medical position as of Q1 2023 after selling out during the quarter.
Centiva Capital sold 170,633 Envoy Medical shares in Q1 2023, an estimated $1.72M.
Centiva Capital first reported a position in Envoy Medical in Q2 2021 and held it in 7 quarters.
Centiva Capital's Envoy Medical position peaked at $1.72M in Q4 2022.
24 funds tracked by Wall St. Rank held Envoy Medical as of Q1 2023.

Based on Centiva Capital's 13F filing for Q1 2023, filed 15 May 2023.